Aragen Life Sciences sets up new facility in HyderabadIllustrative image – not actual.

Aragen Life Sciences, formerly known as GVK BIO, has established a new integrated high-potency development and manufacturing facility named Aragen OneHP at its Nacharam campus in Hyderabad.

Spanning 15,000 sq. ft., the facility integrates discovery, process development, scale-up, and cGMP manufacturing, allowing customers to transition compounds seamlessly from milligram-scale chemistry to multi-kilogram production within a single site. The platform features a manufacturing line designed with an annual capacity of 500 to 600 kg of active pharmaceutical ingredients, specifically engineered to handle complex cytotoxic compounds and targeted oncology treatments.

The inauguration of the facility reinforces Aragen Life Sciences' capabilities in delivering end-to-end, high-potency drug development solutions for complex oncology therapies.

← All latest storiesBack to top →